Diabetes Drug ' Home Run ' Curtailing Kidney Failure Risk Diabetes Drug ' Home Run ' Curtailing Kidney Failure Risk

Canagliflozin also showed cardiovascular benefits in the CREDENCE multicenter trial, with no imbalance in adverse events, investigators shared here at the nephrology world congress.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Nephrology News Source Type: news